(Q77944802)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Dittmer U

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Brooks DM

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Hasenkrug KJ

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

189-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/5550

9 December 2019

exact match

0 references

cites work

T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant

1 reference

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

7 January 2021

Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion

1 reference

7 January 2021

Vaccination with a live retrovirus: the nature of the protective immune response

1 reference

7 January 2021

Prospects for live attenuated HIV

1 reference

7 January 2021

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

7 January 2021

Weakened SIV vaccine still kills

1 reference

7 January 2021

Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus

1 reference

7 January 2021

Specificity of helper T-cells generated from macaques infected with attenuated simian immunodeficiency virus

1 reference

7 January 2021

Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells.

1 reference

7 January 2021

Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

1 reference

7 January 2021

Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus

1 reference

7 January 2021

Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity

1 reference

7 January 2021

Protective immunity induced by live attenuated simian immunodeficiency virus

1 reference

7 January 2021

HIV vaccines--where are we going?

1 reference

7 January 2021

Why do we not have an HIV vaccine and how can we make one? .

1 reference

7 January 2021

Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression

1 reference

7 January 2021

Altered macrophage antigen-presenting cell function following Friend leukemia virus infection

1 reference

7 January 2021

Host-range control of a retroviral disease: Friend erythroleukemia

1 reference

7 January 2021

Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor

1 reference

7 January 2021

Immunoprotective determinants in friend murine leukemia virus envelope protein

1 reference

7 January 2021

Oncogenicity of Friend-virus-infected cells: determination of origin of spleen colonies by the H-2 antigens as genetic markers

1 reference

7 January 2021

Susceptibility to two strains of Friend leukemia virus in mice

1 reference

7 January 2021

Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms

1 reference

7 January 2021

A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus

1 reference

7 January 2021

Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness

1 reference

7 January 2021

Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice

1 reference

7 January 2021

Pathogenesis of street rabies virus infections in resistant and susceptible strains of mice

1 reference

7 January 2021

Antiviral protective immunity induced by major histocompatibility complex class I molecule-restricted viral T-lymphocyte epitopes inserted in various positions in immunologically self and nonself proteins.

1 reference

7 January 2021

Vaccination to prevent persistent viral infection.

1 reference

7 January 2021

CD8+ cell anti-HIV activity: nonlytic suppression of virus replication

1 reference

7 January 2021

Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele

1 reference

7 January 2021

A strategy for prophylactic vaccination against HIV.

1 reference

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

7 January 2021

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

7 January 2021

Progress in the development of an HIV-1 vaccine

1 reference

7 January 2021

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

7 January 2021

beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques

1 reference

7 January 2021

Characterization of monoclonal antibodies reactive with murine leukemia viruses: Use in analysis of strains of friend MCF and friend ecotropic murine leukemia virus

1 reference

7 January 2021

Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses

1 reference

7 January 2021

Different H–2 subregions influence immunization against retrovirus and immunosuppression

1 reference

7 January 2021

Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens

1 reference

7 January 2021

Identifiers

DOI

10.1038/5550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930867%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference